Company Filing History:
Years Active: 2014-2019
Title: Christopher Roberts: Innovator in Medical Measurement and Anti-Viral Research
Introduction
Christopher Roberts is a notable inventor based in Durham, NC, who has made significant contributions to the fields of medical measurement and virology. With a total of two patents to his name, Roberts has developed innovative devices and methods that enhance the accuracy of syringe fluid measurement and provide solutions for viral infections.
Latest Patents
Roberts' latest patents include "Devices, systems, and methods for volumetrically measuring syringe fluid." This invention features a device that incorporates a reference plate, a flange adapter base, and a plunger adapter, which allows for precise volumetric measurement of fluid drawn into a syringe. The device utilizes a displacement sensor to measure the movement of the plunger adapter, converting this measurement into a volumetric reading. Another significant patent is for "Anti-viral compounds, compositions, and methods of use." This patent discloses various compounds and their applications for treating infections caused by viruses in the Flaviviridae family.
Career Highlights
Throughout his career, Christopher Roberts has worked with esteemed organizations such as the University of North Carolina at Chapel Hill and GlaxoSmithKline LLC. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Roberts has collaborated with notable colleagues, including Stephen Eckel and Chase Dubois. These partnerships have further enriched his research and development efforts, leading to innovative solutions in his areas of expertise.
Conclusion
Christopher Roberts stands out as an influential inventor whose work in volumetric measurement and anti-viral research has the potential to impact medical practices significantly. His contributions continue to pave the way for advancements in healthcare technology and treatment methodologies.